Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118257) titled 'To construct an AI-based multimodal biomarker model for predicting restenosis after peripheral artery disease treatment' on Feb. 3.

Study Type: Observational study

Study Design: Sequential

Primary Sponsor: Beijing Hospital

Condition: Peripheral vascular disease

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-03-01

Target Sample Size: Training set:550;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=286929

Disclaimer: Curated by HT Syndication....